Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BrainTemp is a private health technology and medical device company developing non-invasive brain temperature monitoring systems. Its lead and currently disclosed product is BTneo, an FDA-cleared device for continuous brain temperature measurement in neonates, intended for use by qualified healthcare professionals in intensive care, operating room, and recovery settings. The company positions BTneo as the first and only non-invasive continuous brain temperature monitoring system for this population. BrainTemp appears focused on neuroprotection and neonatal critical care rather than therapeutics, with its value proposition centered on improved physiologic monitoring and treatment guidance. Publicly available information suggests the company is venture-backed, privately held, and in the process of commercial rollout rather than operating a traditional drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BrainTemp.